Nxera Pharma Co., Ltd. (TYO:4565)
Japan flag Japan · Delayed Price · Currency is JPY
1,677.00
-68.00 (-3.90%)
Nov 18, 2026, 10:50 AM JST

Nxera Pharma Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
16,61320,36536,20349,06566,55760,087
Cash & Short-Term Investments
16,61320,36536,20349,06566,55760,087
Cash Growth
-41.63%-43.75%-26.21%-26.28%10.77%50.19%
Accounts Receivable
6,7837,7306,6955,0642,4622,138
Other Receivables
2,9123,8674,6436,823140103
Receivables
9,69511,59711,33811,8872,6022,241
Inventory
11,80011,2948,8382,903--
Prepaid Expenses
-1,2051,259790638388
Other Current Assets
1,290421746714592
Total Current Assets
39,39844,46557,85565,11269,94262,808
Property, Plant & Equipment
5,5387,4557,4687,9003,7913,817
Long-Term Investments
2,4402,9194,5503,3081,8016,145
Goodwill
24,56525,83825,69324,62315,306-
Other Intangible Assets
52,11649,23051,91152,2918,57724,215
Long-Term Deferred Tax Assets
6,1824,8794,0213,964--
Other Long-Term Assets
131----
Total Assets
130,252134,787151,498157,19899,41796,985

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4,4347,4944,0524,2441,6281,176
Accrued Expenses
-5681,250-400570
Current Portion of Long-Term Debt
5,7985,7985,7985,941--
Current Portion of Leases
860886892832176193
Current Income Taxes Payable
1,3812443224,640260279
Current Unearned Revenue
-2,2243,1411,3881,450785
Other Current Liabilities
2,9292861771401784,188
Total Current Liabilities
15,40217,50015,63217,1854,0927,191
Long-Term Debt
43,08147,18957,72763,21527,98127,440
Long-Term Leases
2,2183,5063,4833,9851,5771,638
Long-Term Deferred Tax Liabilities
2-1,8571,4902,9222,706
Other Long-Term Liabilities
5,3965,5954,2814,5134,909542
Total Liabilities
66,09973,79082,98090,38841,48139,517

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
48,50747,45047,17246,80741,33541,036
Additional Paid-In Capital
23,54822,12035,07434,04829,52529,100
Retained Earnings
-13,486-17,546-20,942-16,104-8,911-9,768
Treasury Stock
-1,239-3-3-1-1-
Comprehensive Income & Other
6,8238,9767,2172,060-4,012-2,900
Total Common Equity
64,15360,99768,51866,81057,93657,468
Shareholders' Equity
64,15360,99768,51866,81057,93657,468
Total Liabilities & Equity
130,252134,787151,498157,19899,41796,985

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
51,95757,37967,90073,97329,73429,271
Net Cash (Debt)
-35,344-37,014-31,697-24,90836,82330,816
Net Cash Growth
----19.49%31.78%
Net Cash Per Share
-389.16-410.01-353.24-301.85445.85375.78
Filing Date Shares Outstanding
91.3990.4989.989.4581.9281.52
Total Common Shares Outstanding
91.3990.4989.989.4581.9281.52
Working Capital
23,99626,96542,22347,92765,85055,617
Book Value Per Share
701.96674.04762.15746.93707.20704.97
Tangible Book Value
-12,528-14,071-9,086-10,10434,05333,253
Tangible Book Value Per Share
-137.08-155.49-101.07-112.96415.67407.92
Order Backlog
-1,9291,122---